Pharma
Cambridge Cognition investment, Monument Therapeutics, achieves positive Phase I results for novel schizophrenia treatment
Cambridge Cognition (AIM: COG), the brain health software group specialising in digital health products that advance brain health research and treatment, is pleased to report that Monument Therapeutics, in which the Group has a 20% holding, has achieved positive topline results from its...
NIHR BioResource Scientific Conference 2025 goes live today!
Our event platform is now open for you to log in! Please use the email you registered with and set a password. We will kick off the live event at 9.30am but before then, please have a look around, get familiar with the site and check out the available resources. ...
Unpick your Overwhlem - New 1:1 offer from Promote Mental Health
This month we launch a new service at Promote Mental Health. An opportunity to work one to one with Claire Harris unpicking your stress and overwhelm, and coming away with personalised strategies to address the chaos. ...
The ILD patient journey and what to expect
Navigating the journey of interstitial lung disease (ILD) can be overwhelming, filled with uncertainties, misdiagnoses, and emotional challenges. From the first signs of symptoms to receiving an accurate diagnosis and starting treatment, ILD patients often face a long and complex path. ...
Introduction to Drug Development: From Candidate Selection to Patients in Healthcare
AudienceThose who want to understand what is done to bring new treatments to patients, and/or better operate with the language of internal customers. Typically people in non life-science technical roles in our sector – IT, Finance, HR and Admin staff. ...
Astoriom appoints Brittany Jackson as CFO
Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions ...
Biomedical Research with Health Databanks: Privacy and Data Protection Considerations
In early April this year, Prime Minister Starmer announced the UK government's plans to boost biomedical research by ensuring access to large sets of health data. A Health Data Research Service will be set up and host data from various divisions of the National Health Service (the ...
25 Years of Guardtech: Compliance Manager Chris McGinn Q&A
One of the Group’s longest-serving stalwarts gives his take on why quality and compliance is so critical to keeping Guardtech at the apex of the industry’s cleanroom construction providers ...
The European health data space: Key features and opportunities for access and research
In a previous blog post, we briefly outlined the plans of the European Union (EU) to facilitate access to high-quality data for scientific research. Three main EU initiatives aim at enabling such access. The first initiative focusses on the establishment of a network of common Euro...
Privacy implications of secondary use of personal data for scientific research in the European Union
Scientific research is front and centre in innovation policies across Europe, and the European Union (EU)'s research agenda makes no exception. ...